Harika Pulipelli recently attended the AACR Special Conference in Cancer Research: RNAs as Drivers, Targets, and Therapeutics in Cancer, held in Seattle, WA. At the conference, Harika presented her research on “The Ratio of Alternatively Spliced KRAS Isoforms and Its Role in the Tumorigenesis of Colorectal Cancer.” We are immensely proud of Harika for being honored with the merit-based Scholar-In-Training Award. The Hertel Lab is very excited to be conducting cancer research and sharing our findings with the community.
